home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Patient-Specific Cancer Treatment

  August, 31 2006 6:24
your information resource in human molecular genetics
Scientists have discovered a way to cause some cancerous cells to self-destruct. These findings, reported in the October 2006 issue of Nature Chemical Biology, describe the use of a small molecule to 'wake up' the key enzyme -- caspase-3 -- that causes cell death.

Caspase-3 normally exists as a proenzyme, meaning that further processing is required to make the final, active enzyme. This processing is normally performed by other caspases and serves as a signal that something has gone wrong with a cell; it signals that cell death or 'apoptosis' is desired. Paul Hergenrother and colleagues have now used the synthetic compound PAC-1 to trick procaspase-3 into processing itself, generating caspase-3 and causing cell death. They demonstrated, in a variety of cancer cell types, that cell death is correlated with the amount of procaspase-3 present in the cells, with more procaspase-3 resulting in cell death at lower concentrations of PAC-1, while healthy cells remain unaffected.

The variability of procaspase-3 levels in the cell lines tested means that some patients would be more responsive to this therapy than others. As such, this research potentially offers a novel opportunity for individualized cancer therapy.

Author contact:

Paul J Hergenrother (The University of Illinois, Urbana, IL, USA)
E-mail: hergenro@uiuc.edu

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.